Table 1.
CI values of synergistic drug interactions in M4/M5 AML cell lines.
| ML-1 | TRAIL (ng/mL) | Bz (nM) | CI |
| 10.0 | 7.0 | 0.93172 | |
| 25.0 | 7.0 | 0.62343 | |
| 50.0 | 7.0 | 0.51661 | |
| 100.0 | 7.0 | 0.69512 | |
| 250.0 | 7.0 | 1.37954 | |
| ML-2 | TRAIL (ng/mL) | Bz (nM) | CI |
| 10.0 | 4.0 | 0.12802 | |
| 25.0 | 4.0 | 0.07240 | |
| 50.0 | 4.0 | 0.09342 | |
| 100.0 | 4.0 | 0.18088 | |
| 250.0 | 4.0 | 0.47115 | |
| MOLM-13 | TRAIL (ng/mL) | Bz (nM) | CI |
| 10.0 | 8.0 | 0.96874 | |
| 25.0 | 8.0 | 0.85746 | |
| 50.0 | 8.0 | 0.44369 | |
| 100.0 | 8.0 | 0.48190 | |
| 250.0 | 8.0 | 0.55473 | |
| OCI-AML2 | TRAIL (ng/mL) | Bz (nM) | CI |
| 10.0 | 8.0 | 1.27244 | |
| 25.0 | 8.0 | 1.00502 | |
| 50.0 | 8.0 | 0.62569 | |
| 100.0 | 8.0 | 0.50518 | |
| 250.0 | 8.0 | 0.41878 | |
| OCI-AML3 | TRAIL (ng/mL) | Bz (nM) | CI |
| 10.0 | 10.0 | 0.46307 | |
| 25.0 | 10.0 | 0.40560 | |
| 50.0 | 10.0 | 0.40126 | |
| 100.0 | 10.0 | 0.43864 | |
| 250.0 | 10.0 | 0.42473 |